Data / Drug companies / Cefadroxil
Cefadroxil: 15 companies and 40 products in the FDA NDC directory
Cefadroxil is listed in the FDA National Drug Code Directory by 15 companies, with 40 products in commercial distribution. 40 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule; powder, for suspension; tablet, and the newest product started marketing on August 23, 2024.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 15
- Products
- 40
- Generic (ANDA) products
- 40 (100.0%)
- Application numbers
- 6
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list cefadroxil
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| NuCare Pharmaceuticals,Inc. | 5 | capsule | Generic drugs (ANDA) | April 23, 2008 |
| Bryant Ranch Prepack | 4 | capsule | Generic drugs (ANDA) | April 23, 2008 |
| Redpharm Drug | 4 | capsule | Generic drugs (ANDA) | November 1, 2019 |
| Advanced Rx of Tennessee, LLC | 3 | capsule | Generic drugs (ANDA) | August 23, 2024 |
| Aurobindo Pharma Limited | 3 | powder, for suspension; capsule | Generic drugs (ANDA) | April 25, 2013 |
| Direct_Rx | 3 | capsule | Generic drugs (ANDA) | August 7, 2023 |
| Lupin Pharmaceuticals, Inc. | 3 | powder, for suspension; capsule | Generic drugs (ANDA) | April 23, 2008 |
| NorthStar Rx LLC | 3 | powder, for suspension; capsule | Generic drugs (ANDA) | April 25, 2013 |
| Rising Pharma Holdings, Inc. | 3 | powder, for suspension; capsule | Generic drugs (ANDA) | April 25, 2013 |
| PD-Rx Pharmaceuticals, Inc. | 2 | capsule | Generic drugs (ANDA) | April 23, 2008 |
| Preferred Pharmaceuticals Inc. | 2 | capsule | Generic drugs (ANDA) | July 13, 2023 |
| Teva Pharmaceuticals USA, Inc. | 2 | tablet; capsule | Generic drugs (ANDA) | January 31, 2007 |
| A-S Medication Solutions | 1 | capsule | Generic drugs (ANDA) | January 25, 2007 |
| Proficient Rx LP | 1 | capsule | Generic drugs (ANDA) | April 23, 2008 |
| Remedyrepack Inc. | 1 | capsule | Generic drugs (ANDA) | November 22, 2022 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule | 31 | 77.5% |
| Powder, for suspension | 8 | 20% |
| Tablet | 1 | 2.5% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 40 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Cephalosporin Antibacterial | 40 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.